Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9T14
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,495
Award facts
- Contract value 100% obligated
- $35,495.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,495.29 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Dupixent 300 mg/2 ml pen injections. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is scheduled for completion by December 31, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and U.S. Coast Guard. The company maintains an extensive portfolio of brand-name and generic medications, including specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle enables the company to supply pharmaceutical products globally to support military healthcare programs. This specific delivery order for Dupixent, a biologic immunosuppressant used to treat conditions such as atopic dermatitis and asthma, reflects AmerisourceBergen's role in providing specialized medical commodities to support federal health system needs.
Quick answers
Who was awarded contract SPE2DR26F9T14?
SPE2DR26F9T14 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F9T14 worth?
The government has obligated $35,495 on SPE2DR26F9T14.
Is contract SPE2DR26F9T14 an order under another contract?
Yes. SPE2DR26F9T14 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9T14 competed?
The extent of competition for SPE2DR26F9T14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award